Global Ganja Report

The House and Senate appropriations leadership has hammered out a budget bill that includes an historic amendment to curb federal Department of Justice (DoJ) enforcement in medical marijuana states. The measure, which was originally passed by the House in May with a 219-189 vote, aims to prohibit the DoJ from spending taxpayer money to undermine state medical marijuana laws. "This is great news for medical marijuana patients all across the country," said Rep. Sam Farr (D-CA), one of the co-authors of the House measure. "This amendment protects patients while the federal government catches up with the views of the American people. Patients will have access to the care legal in their state without fear of federal prosecution. And our federal dollars will be spent more wisely on fighting actual crimes and not wasted going after patients."

In an unprecedented 219-189 floor vote late May 29, the House of Representatives approved the end of funding for Department of Justice (DoJ) enforcement in medical marijuana states. Advocates are hailing the vote as a major victory that signals a shift in the approach Congress is taking on this issue. The vote was on Amendment No. 25 to the Commerce, Justice & Science (CJS) appropriations bill. One hundred seventy Democrats and 49 Republicans voted in favor of the amendment. "This Congressional vote is a huge victory for patients," said Steph Sherer, executive director of Americans for Safe Access. "No longer will we have to look over our shoulder and worry when the next raid or indictment will prevent us from safely and legally accessing our medicine. This is a game-changer that paves the way for much more policy change to come."

As US Attorney General Eric Holder delivered a commencement speech May 11 for UC Berkeley law school graduates, a plane flew overhead with a banner that read "Holder: End Rx Cannabis War. #Peace4Patients," in protest against recent actions by the Justice Department (DoJ) in the Bay Area. Outside the Hearst Greek Theater, where Holder gave his speech, medical marijuana advocates also handed out fake DoJ recruitment flyers, detailing how the Obama Administration is engaging in harmful tactics that are adversely affecting the lives of hundreds of thousands of patients in California.

Doc Green's Healing Collective, producers of the cannabis-infused Doc Green's Therapeutic Healing Cream, has received a letter from Wells Fargo sating that the business' account has been closed pending review—citing the "nature of the business." Doc Green's co-founder Ramona Moonflower Rubin told Global Ganja Report business is now paralyzed, and the collective is considering its options. Rubin notes the irony: "We are producers of topical cannabis products that don't have any psychoactive effect. They don't get users high, they just provide pain relief when applied directly to the affected area."